Boron citrate in obesity

Not Applicable

• Conditions: obesity.; Obesity due to excess calories; E66.0

• Registration Number: IRCT20220806055624N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

BMI: 30–40 (kg/m²)
Willingness to participate in the study

Exclusion Criteria

Athlete, pregnancy, lactation and menopause in women
Under infertility treatment, taking birth control pills and estrogen
Smoking and history of alcohol consumption
Following a special diet three months before the study
Use of chemical or herbal drugs for weight loss and use of hepatotoxic drugs such as phenytoin, amoxifene, lithium, blood pressure control drugs and blood lipid lowering drugs (statins), drugs that increase insulin sensitivity.
Taking antibiotics or supplements affecting liver enzyme levels
Weight loss surgery in the last year or strict weight loss diets in the last three months
Using corticosteroid and non-steroidal anti-inflammatory drugs and any supplements for 3 months before the study or during the study
Cardiovascular diseases, liver, kidney, intestinal, thyroid and parathyroid dysfunction, biliary disease, known autoimmune diseases, polycystic ovary syndrome, cancers and malabsorption diseases such as sprue and Crohn's
Having symptoms of infectious or inflammatory disease or recent surgery
Performed or candidate for liver transplant

Study & Design

• Study Type: interventional
• Study Design: Not specified